Senior Fitness - Exercise and Nutrition for Aging Men and Women
FREE Article Feed for your website.
Home Ownership Magazine
Party Planning Information
Article Marketing Resources
Bio-Medical Research Article Database
Informative Articles on Life, Love and Happiness
Tutorials on Business to Writing
Famous Quotes from Famous People
Song Lyric Information
New US Patent Information
Comprehensive List of Content by Category
Online Auctions and Shopping Related Articles
Article Search
Most Recent Articles
Title: Wireless, ground link-based aircraft data communication system with roaming feature
Patent Number: 7,426,387 Issued on 09/16/2008 to Wright,   et al.

Title: Beam laydown for hopped satellite downlink with adaptable duty cycle
Patent Number: 7,426,386 Issued on 09/16/2008 to Yousefi,   et al.

Title: Communication device and method for communicating over a digital mobile network
Patent Number: 7,426,385 Issued on 09/16/2008 to Mortensen,   et al.

Title: Network communication system including a database of codes and corresponding telephone numbers
Patent Number: 7,426,384 Issued on 09/16/2008 to Murray,   et al.

Title: Wireless LAN intrusion detection based on location
Patent Number: 7,426,383 Issued on 09/16/2008 to Wang,   et al.

Title: Contact validation and trusted contact updating in mobile wireless communications devices
Patent Number: 7,426,382 Issued on 09/16/2008 to Aerrabotu,   et al.

Title: Device billing agent
Patent Number: 7,426,381 Issued on 09/16/2008 to Maes

Title: Location derived presence information
Patent Number: 7,426,380 Issued on 09/16/2008 to Hines,   et al.

Title: Method and system for sound mitigation during initiation of a packet-based real-time media session
Patent Number: 7,426,379 Issued on 09/16/2008 to Stewart,   et al.

Title: Separation of cochannel FM signals
Patent Number: 7,426,378 Issued on 09/16/2008 to Stanners

Title: Sigma delta (.SIGMA..DELTA.) transmitter circuits and transceiver using the same
Patent Number: 7,426,377 Issued on 09/16/2008 to Tanaka,   et al.

Title: Receiver having digital automatic gain control
Patent Number: 7,426,376 Issued on 09/16/2008 to Srinivasan,   et al.

Title: Combination of high-side and low-side current sensing in system for providing power over communication link
Patent Number: 7,426,374 Issued on 09/16/2008 to Dwelley,   et al.

Title: Electrically tuned resonance circuit using piezo and magnetostrictive materials
Patent Number: 7,426,373 Issued on 09/16/2008 to Clingman,   et al.

Title: Piecewise linearizer circuit for radio frequency amplification
Patent Number: 7,426,372 Issued on 09/16/2008 to Quilligan

Title: Radio communication quality measuring apparatus, radio communication quality measuring method and radio base station
Patent Number: 7,426,370 Issued on 09/16/2008 to Nakao,   et al.

Title: Bluetooth appliance having non-memory programmable identification address storing device and telecommunication method thereof
Patent Number: 7,426,369 Issued on 09/16/2008 to Lee

Title: Satellite broadcasting converter, control circuit incorporated therein, and detector circuit used in such control circuit
Patent Number: 7,426,368 Issued on 09/16/2008 to Hirai

Title: Sheet processing apparatus and image forming apparatus
Patent Number: 7,426,367 Issued on 09/16/2008 to Hirai

Title: Image forming apparatus and paper ejection method of image forming apparatus
Patent Number: 7,426,366 Issued on 09/16/2008 to Shishikura

Title: Waste toner collecting apparatus and image forming apparatus
Patent Number: 7,426,365 Issued on 09/16/2008 to Uchihashi

Title: Fixing method, fixing device, and image forming apparatus
Patent Number: 7,426,364 Issued on 09/16/2008 to Kagawa,   et al.

Title: Developer supply container with shutter movement prevention feature
Patent Number: 7,426,363 Issued on 09/16/2008 to Murakami,   et al.

Title: Conveyor device and image forming apparatus
Patent Number: 7,426,362 Issued on 09/16/2008 to Takami

Title: Developer mixing apparatus having four ribbon blenders
Patent Number: 7,426,361 Issued on 09/16/2008 to Thompson,   et al.

Title: Developing apparatus
Patent Number: 7,426,360 Issued on 09/16/2008 to Arimoto,   et al.

Title: Color image forming device having a movable toner supply member being disposable in a laser light path
Patent Number: 7,426,359 Issued on 09/16/2008 to Tanda

Title: Image forming apparatus and method having a cleanerless image forming unit
Patent Number: 7,426,358 Issued on 09/16/2008 to Yoshida,   et al.

Title: Fixing unit and image forming apparatus equipped with the fixing unit
Patent Number: 7,426,357 Issued on 09/16/2008 to Mori

Title: Developer cartridge, print process cartridge, and image forming apparatus
Patent Number: 7,426,356 Issued on 09/16/2008 to Ota

Title: Tandem photosensitive-member unit having grip part
Patent Number: 7,426,355 Issued on 09/16/2008 to Okabe

Title: Image forming device and process cartridge
Patent Number: 7,426,354 Issued on 09/16/2008 to Ozawa,   et al.

Title: Image forming apparatus with variable convey speed control between transfer device and fixing device
Patent Number: 7,426,353 Issued on 09/16/2008 to Sakakibara

Title: Image formation apparatus
Patent Number: 7,426,352 Issued on 09/16/2008 to Moriyama,   et al.

Title: Image forming apparatus and layer thickness calculating method
Patent Number: 7,426,351 Issued on 09/16/2008 to Yamaguchi,   et al.

Title: Mass flowmeter and method for correcting the measurement signal of a mass flowmeter
Patent Number: 6,889,561 Issued on 05/10/2005 to Hussain,   et al.

Title: Method and device for generating an air stream in a duplicating machine
Patent Number: 6,889,609 Issued on 05/10/2005 to Braun,   et al.

Title: Low operating pressure gas scrubber
Patent Number: 6,893,484 Issued on 05/17/2005 to Thomas

Title: Process for the production of grain oriented electrical steel strips
Patent Number: 6,893,510 Issued on 05/17/2005 to Fortunati,   et al.

Title: Antidepressant drugs and methods
Patent Number: 6,759,435 Issued on 07/06/2004 to Chen

Title: Method of manufacturing a semiconductor device with self-aligned contacts
Patent Number: 7,151,025 Issued on 12/19/2006 to Itabashi,   et al.

Title: Method and apparatus for adjusting power control setpoint in a wireless communication system
Patent Number: 6,763,244 Issued on 07/13/2004 to Chen,   et al.

Title: LNG production in cryogenic natural gas processing plants
Patent Number: 6,889,523 Issued on 05/10/2005 to Wilkinson,   et al.

Title: Game calling device
Patent Number: 7,145,067 Issued on 12/05/2006 to Pfortmiller,   et al.

Title: Fiber optic connector and method
Patent Number: 7,147,385 Issued on 12/12/2006 to Zimmel,   et al.

Title: System and method of adaptively reconfiguring buffers
Patent Number: 7,143,263 Issued on 11/28/2006 to Anand,   et al.

Title: Semiconductor device and method for manufacturing the same
Patent Number: 7,151,034 Issued on 12/19/2006 to Lee,   et al.

Title: Laser assisted magnetic recording apparatus and method
Patent Number: 6,762,977 Issued on 07/13/2004 to Gage,   et al.

Title: Disposal of cement waste from chute
Patent Number: 7,147,360 Issued on 12/12/2006 to Elefsrud

Title: Semiconductor memory device having a circuit for fast operation
Patent Number: 6,762,967 Issued on 07/13/2004 to Tanizaki,   et al.

Title: Method of manufacturing semiconductor device
Patent Number: 7,151,017 Issued on 12/19/2006 to Ohnuma

Title: Semiconductor wafer test system
Patent Number: 7,151,003 Issued on 12/19/2006 to Oishi

Title: Patient support pad with repositionable pressure source
Patent Number: 7,146,660 Issued on 12/12/2006 to Heimbrock

Title: Digital broadcast receiving device
Patent Number: 7,146,633 Issued on 12/05/2006 to Yamaguchi,   et al.

Title: Multi-site cardiac stimulation device and method for detecting retrograde conduction
Patent Number: 7,146,215 Issued on 12/05/2006 to Mo

Title: Funnel in cathode ray tube
Patent Number: 6,765,343 Issued on 07/20/2004 to Kim

Title: Open hydraulic circuit including a relief valve device
Patent Number: 7,150,150 Issued on 12/19/2006 to Bigo,   et al.

Title: System for and method of toner flow control
Patent Number: 6,760,555 Issued on 07/06/2004 to Dougherty,   et al.

Title: Semiconductor filter circuit and method
Patent Number: 6,953,980 Issued on 10/11/2005 to Escoffier,   et al.

Title: Gas turbine engine
Patent Number: 7,153,091 Issued on 12/26/2006 to Stephenson,   et al.

Title: Modular air conditioner for a bus
Patent Number: 6,761,038 Issued on 07/13/2004 to Bushnell,   et al.

Title: Method for fabricating electrical connection structure of circuit board
Patent Number: 7,151,050 Issued on 12/19/2006 to Hsu,   et al.

Title: Water heater having self-powered low NOx burner/fuel-air delivery system
Patent Number: 6,761,134 Issued on 07/13/2004 to Trant

Title: Satellite broadcast receiving converter with lower power consumption
Patent Number: 7,136,618 Issued on 11/14/2006 to Kato,   et al.

Title: Apparatus and method for managing power of a battery
Patent Number: 6,765,369 Issued on 07/20/2004 to Rhee,   et al.

Title: Pneumatic surgical prone head support and system
Patent Number: 7,146,664 Issued on 12/12/2006 to Grosvenor

Title: Semiconductor device with flexible redundancy system
Patent Number: 6,762,964 Issued on 07/13/2004 to Takase

Title: Hydraulic actuator having disc valve assembly
Patent Number: 7,143,684 Issued on 12/05/2006 to Dourson,   et al.

Title: Method of manufacturing thin-film magnetic head
Patent Number: 7,155,809 Issued on 01/02/2007 to Sasaki,   et al.

Title: Fire extinguisher kit, device and method of using same
Patent Number: 7,147,061 Issued on 12/12/2006 to Tsutaoka,   et al.

Title: On-line system and method for processing information relating to the wear of turbine components
Patent Number: 7,149,632 Issued on 12/12/2006 to Gao,   et al.

Title: Control of software via bundling
Patent Number: 7,158,248 Issued on 01/02/2007 to Smith,   et al.

Title: Cardiac harness for treating congestive heart failure and for defibrillating and/or pacing/sensing
Patent Number: 7,149,588 Issued on 12/12/2006 to Lau,   et al.

Title: Fabrication apparatus for an assembly of vanes for an architectural covering
Patent Number: 7,146,694 Issued on 12/12/2006 to Colson,   et al.

Title: System and method for automated play of lottery games
Patent Number: 6,964,611 Issued on 11/15/2005 to Packes, Jr.,   et al.

Interferon-γ promotes abortion due to Brucella infection in pregnant mice

Home    Author Login    Submit Article    Article Search    Add Your Link    Edit Your Link    Contact Us    Advertising    Disclaimer

   

 
Web LinkGrinder.com

Top Breaking News
     Greek, Cypriot Leaders Resume Unification Talks in Nicosia by Nathan Morley
     Indonesia Tobacco Sales Grow, Raising Health Fears
     South Korea Allows Top Defector to Travel Overseas by VOA News

Interferon-γ promotes abortion due to Brucella infection in pregnant mice

Interferon-γ promotes abortion due to Brucella infection in pregnant mice
Suk Kim1 , Dong Soo Lee2 , Kenta Watanabe1 , Hidefumi Furuoka3 , Hiroshi Suzuki2, 4 and Masahisa Watarai1
1Department of Applied Veterinary Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
2Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
3Department of Pathological Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
4Department of Development and Medical Technology, Graduate School of Medicine, The University of Tokyo, Hongo, Tokyo 113-0033, Japan

BMC Microbiology 2005, 5:22     doi:10.

Category: BMC-Microbiology

Submit your Articles Here!
Subscribe to Articles! Get new articles everyday for your favorite subjects!! - www.Amazines.com
Related Articles

Interferon-γ promotes abortion due to Brucella infection in pregnant mice
Suk Kim1 , Dong Soo Lee2 , Kenta Watanabe1 , Hidefumi Furuoka3 , Hiroshi Suzuki2, 4 and Masahisa Watarai1
1Department of Applied Veterinary Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
2Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
3Department of Pathological Science, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan
4Department of Development and Medical Technology, Graduate School of Medicine, The University of Tokyo, Hongo, Tokyo 113-0033, Japan

BMC Microbiology 2005, 5:22     doi:10.1186/1471-2180-5-22

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1471-2180/5/22

Received   3 December 2004

Accepted   4 May 2005

Published   4 May 2005


© 2005 Kim et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

Outline   Abstract


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

 

Background The mechanisms of abortion induced by bacterial infection are largely unknown. In the present study, we investigated abortion induced by Brucella abortus, a causative agent of brucellosis and facultative intracellular pathogen, in a mouse model.

Results High rates of abortion were observed for bacterial infection on day 4.5 of gestation, but not for other days. Regardless of whether fetuses were aborted or stayed alive, the transmission of bacteria into the fetus and bacterial replication in the placenta were observed. There was a higher degree of bacterial colonization in the placenta than in other organs and many bacteria were detected in trophoblast giant cells in the placenta. Intracellular growth-defective virB4 mutant and attenuated vaccine strain S19 did not induce abortion. In the case of abortion, around day 7.5 of gestation (period of placental development), transient induction of IFN-γ production was observed for infection by the wild type strain, but not by the virB4 mutant and S19. Neutralization of IFN-γ, whose production was induced by infection with B. abortus, served to prevent abortion.

Conclusion These results indicate that abortion induced by B. abortus infection is a result of transient IFN-γ production during the period of placental development.
 

Outline   Background


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

 
Brucellosis is a widespread and economically important infectious disease of animals and humans caused by members of the genus Brucella. Brucella spp. are small gram-negative, facultative intracellular pathogens that cause abortion, retained placenta and infertility in numerous domestic and wild mammals, and a disease known as undulant fever in humans [1,2]. Infection in humans is almost exclusively due to zoonosis, either through direct contact with infected animals or from contaminated dairy products [3]. The mouse model, particularly that using the unpregnant mouse, has been used extensively to study some aspects of the pathogenesis of brucellosis [4]. While brucellosis is known to primarily affect the reproductive tract in the natural host and has been much studied, little is known regarding the cellular and molecular mechanisms of Brucella infection in the pregnant mouse [5]. There have been no studies on the induction of abortion by Brucella infection in the pregnant mouse. A key aspect of the virulence of Brucella is its ability to proliferate within professional and non-professional phagocytic host cells, thereby successfully bypassing the bactericidal actions of phagocytes, which is thought to explain its virulence and ability to cause chronic infections [6,7]. The molecular mechanisms and genetic basis for its intracellular survival and replication, however, are not understood completely. Recent studies with non-professional phagocyte HeLa cells show that Brucella inhibits phagosome-lysosome fusion and transits through an intracellular compartment that resembles autophagosomes. Bacteria replicate in a different compartment, containing protein markers normally associated with the endoplasmic reticulum, as shown by confocal microscopy and immunogold electron microscopy [8-10]. Pregnancy leads to a generalized suppression of the adaptive immune system, typified by significantly decreased cell-mediated immunity and reduced T helper cell (Th) 1 responsiveness [11-13]. This immunosuppressed state prevents maternal rejection of the fetus but has the unfortunate consequence of increasing maternal susceptibility to certain infectious agents [14,15]. Immunity against B. abortus is principally mediated by cellular immune responses since it is an intracellular pathogen, and involves antigen-specific T-cell activation of CD4 and CD8 T cells and humoral responses. Protection of the host against B. abortus infection is thought to be mediated primarily by a Th1 type of immune response [16]. For many other intracellular bacterial and protozoan pathogens, it has been shown that interferon-γ (IFN-γ) is an important component of Th1 immune responses and contributes to control through its ability to stimulate macrophages to kill more microbes. The role of IFN-γ in the control of B. abortus infections has been demonstrated by supplementing BALB/c mice with recombinant IFN-γ, when such treatment resulted in a 10-fold decrease in the number of bacteria at 1 week after infection [17]. It has also been shown that neutralizing endogenous IFN-γ by administering anti-IFN-γ monoclonal antibodies results in a decrease in control [16]. Despite these results, however, the role of cytokines in the control of B. abortus infection in the pregnant mouse is still unknown. In the present study, we investigated the pathogenesis of B. abortus in the pregnant mouse and established a mouse model for abortion induced by B. abortus infection. We noted that IFN-γ plays an important role in the induction of abortion by B. abortus infection.
 

Outline   Results


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

Figures


Figure 1
B. abortus infection causes abortion in pregnant mice


Figure 2
B. abortus infection predominantly in placenta


Figure 3
B. abortus predominantly invades into trophoblast giant cells in placenta


Figure 4
Transient increase in IFN-γ in pregnant mice induced by B. abortus infection


Figure 5
Preventing abortion by neutralizing IFN-γ


Tables


Table 1
B. abortus infection in pregnant mice.


Table 2
Infection of pregnant mice with B. abortus virB4 mutant or vaccine strain S19 on day 4.5 of gestation.

 

B. abortus infection causes abortion in pregnant mice In order to construct a mouse model of abortion due to B. abortus infection, the numbers of aborted fetuses in infected mice were counted on day 18.5 of gestation. For infection with wild type B. abortus on day 4.5 of gestation, all fetuses, except for those of 1 mouse (No. 2), were aborted (98.4% abortion) (Table 1) (Fig. 1). For infection on days 3.5, 6.5 and 9.5 of gestation, the majority of fetuses were still alive (28.1–37.3% abortion), and no abortion was observed for infection on day 14.5 of gestation (Table 1) (Fig. 1). The endpoint number of delivered mice in pregnant mice infected on day 4.5 of gestation was 2, but that in pregnant mice infected on the other days of gestation or in uninfected pregnant mice was 16. Replicating bacteria were observed in both aborted fetuses and those that lived, and there were no significant differences in bacterial infection rates between live (average 3.43 log CFU) and aborted fetuses (average 4.10 log CFU) (Table 1). These experiments were performed at least three times with the same results.

B. abortus infection predominantly in placenta It is well known that the placenta plays an integral role in the pathogenesis of congenital infections. However, the placental factors controlling these processes are not completely understood. To investigate the role of the placenta in B. abortus infection, we examined the placental colonization of the wild type strain. Replicating bacteria were observed in both the placentas of live and aborted fetuses, and the difference between the bacterial growth rate in the placenta of live (average 7.12 log CFU) and aborted fetuses (average 7.17 log CFU) was not significant (Table 1). The bacterial growth rate in the spleen was lower than that in the placenta in all cases (Table 1). In order to check whether B. abortus colonizes the placenta predominantly, bacterial growth in the liver, lung and kidney were measured in addition to that in the spleen and placenta for infection on day 6.5 of gestation. As expected, colonization by B. abortus was much greater in the placenta than in the other organs (Fig. 2). Immunostaining of bacteria infected placenta specimens revealed that bacteria were present in numerous trophoblast giant cells (TGC) along the periphery of the placenta. Bacteria were also observed in neutrophils associated with the regressing deciduas capsularis or free within the newly formed uterine lumen adjacent to this region of the placenta (Fig. 3). Replicating bacteria were observed in TGC in both the placentas of live and aborted fetuses (data not shown).

Type IV secretion system of B. abortus contributes to abortion indirectly As the internalization and intracellular replication of B. abortus are controlled by the type IV secretion system [18,19], on day 4.5 of gestation, pregnant mice were infected with the virB4 mutant, which does not have the ability of intracellular replication [20,21]. The inoculation of pregnant mice with the virB4 mutant did not induce abortion. Bacterial growth, however, was observed in the fetus, placenta and spleen (Table 2). We also observed that attenuated live vaccine strain S19 did not induce abortion (Table 2), even though in contrast to the virB4 mutant it has been seen to have replication capability in macrophages [22,23]. These results suggest that the type IV secretion system may not contribute to abortion directly when mice were infected with B. abortus, because S19 has intact virB genes.

Transient increase in IFN-γ in pregnant mice induced by B. abortus infection Though fetal tissues possess paternal antigens, the fetus is thought to be insulated from rejection by the maternal immune system. The precise cellular and molecular mechanisms underlying the maintenance of pregnancy and the induction of abortion, however, remain unclear. As recent studies have shown that Th1 cytokines, such as interferon-γ (IFN-γ) and tumor necrosis factor α (TNF-α), induce abortion [24], we decided to determine if IFN-γ and TNF-α contribute to the induction of abortion by B. abortus infection and measured the production of IFN-γ and TNF-α by ELISA in pregnant mice infected on day 4.5 of gestation. A large amount of induced IFN-γ production was observed at 3 days after infection with the wild type strain (day 7.5 of gestation) but this production of IFN-γ then decreased rapidly (Fig. 4A). A similar pattern of IFN-γ induction was observed after infecting unpregnant mice with the wild type strain. However, neither the virB4 mutant nor the attenuated live vaccine strain S19 induced IFN-γ production (Fig. 4A). In addition, no significant induction of TNF-α production was observed in the infected pregnant mice (Fig. 4B). These results imply that IFN-γ contributes to abortion due to B. abortus infection, and increased production of IFN-γ around day 7.5 of gestation may be critical, but that TNF-α is not significantly involved.

Preventing abortion by neutralizing IFN-γ production To determine if abortion is prevented by neutralizing the IFN-γ produced as a result of bacterial infection, pregnant mice were inoculated with monoclonal anti-IFN-γ antibody 1 day before infection with B. abortus, which was done on day 4.5 of gestation. Thereafter, the serum levels of IFN-γ and abortion rates were recorded. A large amount of induced IFN-γ production was observed 3 days after infection (day 7.5 of gestation) in the pregnant mice and unpregnant control for mice without antibody, and this production was inhibited in mice inoculated monoclonal anti-IFN-γ antibody for both pregnant mice and the unpregnant control (Fig. 5A). Also, while abortions were observed in the untreated pregnant mice as before, none were seen in pregnant mice inoculated with anti-IFN-γ antibody (Fig. 5B). These results indicate that IFN-γ production contributes to abortion due to B. abortus infection in pregnant mice.
 

Outline   Discussion


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

 
In the present study we investigated abortion induced by B. abortus infection in a mouse model. In a previous study, Tobias et al. observed no abortion in pregnant BALB/c mice infected with B. abortus virulent strain 2308 on day 9 of gestation, but the bacteria multiplied in the placenta and could be identified in trophoblast giant cells (TGC) [5]. In our mouse model, high abortion rates were seen with bacterial infection on day 4.5 of gestation and lower rates were observed when infection was on day 9.5 of gestation. It thus seems that the day of infection during gestation is critical for induction of abortion in mouse models, and this may explain the difference between our results and those of the previous study. Through inoculation with wild type B. abortus on day 4.5 of gestation, an increase in the production of IFN-γ was induced around day 7.5 of gestation. It is thought that the serum IFN-γ level in this period of gestation is relevant to the maintenance of the fetus in the pregnant mice and when the amount of IFN-γ increases during this critical period of pregnancy, abortion may occur [13]. And we observed that abortion due to bacterial infection was indeed prevented when the amount of IFN-γ decreased during the critical period due to neutralization with anti-IFN-γ monoclonal antibody. Cytokine profiles have been observed to have physiological implications for pregnancy, perhaps the most profound being the detrimental affect of T helper cell (Th) 1 cytokines such as IFN-γ and TNF-α, and associated cells and mediators. Thus, natural killer (NK) cells, IFN-γ, TNF-α and nitric oxide (NO) can be deleterious to the well-being of the fetoplacental unit, and capable of inducing abortion and fetal resorption [13]. Our results indicated that the Th1 cytokine IFN-γ play a key role in pregnancy. Our study and that of Tobias et al. showed that B. abortus replicated preferentially in the TGC in the placenta [5]. The mechanism for this is unclear. Erythritol, a sugar alcohol synthesized in the ungulate placenta and known to stimulate the growth of virulent strains of B. abortus, has been credited with the preferential localization of this bacterium within the placenta of ruminants [25,26]. Although very low concentrations of erythritol are found in the placentas of rodents [25], B. abortus will localize and proliferate preferentially in their placenta [[5,27], this study]. While the growth of attenuated vaccine strain S19 was inhibited by erythritol, but its growth was still preferentially localized in the ruminant placenta [26]. Two placental regions can be recognized: a junctional zone and a labyrinth zone. The junctional zone is comprised of stem cells and three differentiated cell types: TGC, spongiotrophoblast cells, and glycogen cells. TGC arise by endoreduplication, are situated at the maternal-placental interface, and are one of the major endocrine cells of the placenta [28]. TGC are polyploidy cells that play a crucial role during implantation and in remodeling of the embryonic cavity, avoidance of maternal immune rejection and promotion of maternal blood flow to the implantation site [29]. TGC should have been hijacked by B. abortus so that cell functions were not exhibited completely, this leading to abortion due to inhibition of implantation and placental development. However, we observed replicating bacteria in the TGC in both placentas of live and aborted fetuses. TGC, spongiotrophoblasts and the labyrinth zone are established from day 8.5 to 10.5 of gestation and comprise the definitive placenta that persists until the end of gestation [29]. Therefore, abortion-inducing factors should act just before day 8.5 of gestation, adding to bacterial infection in the TGC. As abortion occurs in pregnant mice when IFN-γ production is induced by the bacterial infection around day 7.5 of gestation, IFN-γ may influence the development of TGC. In this regard, IFN-γ has been shown to inhibit the cells of the trophoblast lineage outgrowth and trophoblast cell invasion to be accelerated in mice with genetic deficiency in the IFN-γ or IFN-γ receptor [30]. Presumably, IFN-γ production induced by bacterial infection inhibits the development of TGC and B. abortus invades the remaining small number of TGC around day 7.5 of gestation. TGC completely lose all of their function due to the effect of IFN-γ and bacterial replication inside them. Natural killer (NK) cells are large granular lymphocytes found in peripheral blood and also in the maternal decidua during pregnancy. The actions of NK cells on trophoblast lineage cells are likely mediated by NK cell secretory products, including cytokines, and may be direct or indirect. Uterine NK cells produce several cytokines and are the primary source of INF-γ in the metrial grand [30,31]. IFN-γ has been implicated as a major mediator of uterine NK cell function during pregnancy [32,33]. Trophoblast cells are among a variety of different IFN-γ targets, and in vitro trophoblast cell differentiation, survival, and outgrowth are affected by IFN-γ [30,34]. IFN-γ is a crucial cytokine for Brucella immunity [35,36]. The major function of IFN-γ in Brucella immunity is the stimulation of bactericidal activity in macrophages, host cells of Brucella. However, the function of IFN-γ is more diverse than the induction of bactericidal function and includes the stimulation of antigen presentation through class I and class II MHC molecules, the orchestration of leukocyte-endothelium interactions, the effects on cell proliferation and apoptosis, as well as stimulation and repression of a variety of genes whose functional significance remains obscure [37]. Though a previous study found that little role for NK cells in controlling brucellosis in unpregnant mice when NK cells were depleted by administering monoclonal antibody despite the activation of these cells following infection [38], NK cells may play a role in controlling brucellosis in pregnant mice because the modulation of host immune responses differs between pregnant mice and unpregnant normal mice [39]. The virB4 mutant, which is defective intracellular growth, did not cause abortion in pregnant mice, suggesting that the type IV secretion system of B. abortus contributes to abortion induced by bacterial infection. Our results also showed that the virB4 mutant replicated in the placenta. Presumably, virB4 mutant replicates extracellulary in the placenta due to maternal immunosuppression during pregnancy [40]. Wild type B. abortus internalizes into macrophages by swimming on the cell surface with generalized membrane ruffling for several minutes, a process termed "swimming internalization", after which the bacteria are enclosed by macropinosomes [41]. In this period, the phagosomal membrane continues to maintain a dynamic state. Lipid raft-associated molecules, such as glycosylphosphatidylinositol (GPI)-anchored proteins, GM1 ganglioside and cholesterol, have been shown to be selectively incorporated into macropinosomes containing B. abortus. While late endosomal marker lysosomal-associated membrane protein (LAMP)-1 and host cell transmembrane proteins are excluded from the macropinosomes. The disruption of lipid rafts on macrophages markedly inhibits the type IV secretion system-dependent macropinocytosis and intracellular replication [21]. Thus, B. abortus may internalize into TGC by lipid rafts-dependent pathway like that of macrophages, and such internalization and intracellular replication of B. abortus may contribute to induction of IFN-γ in pregnant mice. Our recent study showed that B. abortus Hsp60 (a member of the GroEL family of chaperonins) was secreted on the bacterial surface through the type IV system and that it can interact with the cellular prion protein (PrPC) on macrophages [41]. This interaction is important for establishment of B. abortus infection. As prion protein accumulates in the placenta [42], PrPC may be involved in the internalization of B. abortus into TGC. Many vertically transmitted pathogens are detrimental to the welfare of livestock. Among these are Listeria monocytogenes, Chlamydophila abortus, Toxoplasma gondii, Neospora caninum, bovine viral diarrhoea virus (BVDV) and Border disease virus (BDV). These diverse organisms, ranging from bacteria to apicomplexan protozoa and RNA viruses, share some common features. They give rise to mild and often inapparent disease in non-pregnant animals but cause abortion in ruminants and also in human beings in some cases. However, the disease processes and mechanisms by which they cause abortion are different [39]. IFN-γ and TNF-α are central to host immunity against listeriosis, but can compromise fetal survival [13]. Pregnant mice mount lower levels of protective Th 1 cytokines and are unable to eliminate the pathogen. This leads to severe necrotizing hepatitis and bacteria-induced placental necrosis, increasing the incidence of postimplantation loss and a poor pregnancy response [43].
      Conclusion


 
B. abortus appears to be able to exploit the very precise regulatory processes that control immune responsiveness during pregnancy. Our observations suggest that the generation of inflammatory responses in the maternal periphery and at the maternofetal interface are detrimental for fetal survival and this has important implications for pathogen control during pregnancy. Therefore, vaccination strategies to control B. abortus have to be carefully designed and implemented appropriately to prevent the generation of inappropriate inflammatory responses that might affect the outcome of pregnancy. Thus, using our mice model, we should investigate the mechanism of abortion due to B. abortus infection in more detail and develop on methods for the prevention of abortion that are safer than current control programs.
 

Outline   Methods


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

 

Bacterial strains and mice All B. abortus derivatives were from 544 (ATCC23448) smooth virulent B. abrotus biovar 1 strains. Ba598 (544ΔvirB4) and B. abortus vaccine strain S19 were used in this study [20]. B. abortus strains were maintained as frozen glycerol stocks and cultured on Brucella broth (Becton Dickinson) or Brucella broth containing 1.5% agar.

Mice Six to ten-week-old ICR female mice were individually mated to 6- to 10-week-old ICR male mice. The parent mice were obtained from CLEA Japan. Day 0.5 of gestation was the day the vaginal plug was observed. The normal gestational time for these mice is 19 days.

Virulence in pregnant mice Groups of four or five pregnant mice were infected intraperitoneally with approximately 104 CFU of brucellae in 0.1 ml saline at the indicated days of gestation. On day 18.5 of gestation, their fetus, placenta, spleen, liver, lungs, and kidneys were removed and homogenized in saline. Tissue homogenates were serially diluted with PBS and plated on Brucella agar to count the number of CFU in each spleen. Fetuses were determined to be alive if there was a heartbeat, and dead if there was no heartbeat.

Histology Placentas not used for bacterial culture were fixed in situ within uteri in 10% neutral buffered formalin and processed routinely for histologic examination and scoring using Meyer's hematoxylin stain. Specific labeling of B. abortus in placental sections was performed using the Dako EnVision System with anti-B. abortus rabbit serum [21].

Cytokine measurement The level of serum IFN-γ and TNF-α were measured for infected and uninfected virgin and pregnant ICR mice. Groups of five mice were infected intraperitoneally with approximately 104 CFU of brucellae in 0.1 ml saline on day 4.5 of gestation, and blood was collected at 1, 3, 5, 7 or 10 days after infection. Blood was collected at the same time periods for uninfected mice. On day 18.5 of gestation, their uteruses were removed and a judgment was made as to whether mice were pregnant or not. Serum levels of IFN-γ and TNF-α were measured with an enzyme linked immunosorbent assay (ELISA) kit (PIERCE Endogen) according to the instructions of the manufacturer.

In vivo depletion of IFN-γ IFN-γ was neutralized in the mice by administering anti-mouse IFN-γ monoclonal antibody (clone HB170) in vivo using 1 mg of antibody in a volume of 0.5 ml intraperitoneally 24 h before infection. Control mice were given 1 mg of normal rat IgG in 0.5 ml according to the same injection schedule as the corresponding anti-IFN-γ monoclonal antibody treatment groups. Bacterial infection was done as described above. Blood was collected at 1, 3, 5, 7 or 10 days after infection, and the serum levels of IFN-γ and TNF-α were measured with an ELISA kit as described above. On day 18.5 of gestation, their uteruses were removed and a judgment was made as to whether mice were pregnant or not. Fetuses were determined to be alive if there was a heartbeat, and dead if there was no heartbeat.

Statistical analysis All statistical analysis were calculated using Student t test.
      Authors' contributions


 
SK carried out all virulence assays and analysis of the data. DSL and KW carried out mice mating and maintenances. HF carried out pathological experiments. HS and MW conceived of the study and participated in its design and coordination.
      Acknowledgements


 
We thank Drs. Neeraj Rana and Alexander Cox for critical reading of the manuscript, and Dr Yoshitaka Omata for valuable discussion. This work was supported, in part, by grants from Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science, and Scientific Research (16017207 and 16790250), and the Japan Society for the Promotion of Science, and a grant from the Akiyama Fundation.
 

Outline   References


Abstract Background Results Discussion Conclusion Methods Authors' contributions Acknowledgements References

 

1.   Delrue RM, Martinez-Lorenzo M, Lestrate P, Danese I, Bielarz V, Mertens P, De Bolle X, Tibor A, Gorvel JP, Letesson JJ: Identification of Brucella spp. genes involved in intracellular trafficking.
Cell Microbiol 2001, 3:487-497.

    Return to citation in text: [1]

 

2.   Detileux PG, Deyoe BL, Cheville NF: Entry and intracellular localization of Brucella spp. in Vero cells: fluorescence and electron microscopy.
Vet Pathol 1990, 27:317-328.

    Return to citation in text: [1]

 

3.   Zavala I, Nava A, Guerra J, Quiros C: Brucellosis.
Infect Dis Clin N Am 1994, 8:225-241.

    Return to citation in text: [1]

 

4.   Enright FM: The pathogenesis and pathibiology of Brucella infection in domestic animals.
In Animal Brucellosis. Edited by: Nielsen K and Duncan JR. CRC Press, Boca Raton, FL; 1990:301-320.

    Return to citation in text: [1]

 

5.   Tobias L, Cordes DO, Schurig GG: Placental pathology of the pregnant mouse inoculated with Brucella abortus strain 2308.
Vet Pathol 1993, 30:119-129.

    Return to citation in text: [1] [2] [3] [4]

 

6.   Pizarro-Cerda J, Moreno E, Sanguedolce V, Mege JL, Gorvel JP: Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.
Infect Immun 1998, 66:2387-2392. [PubMed Central Full Text]

    Return to citation in text: [1]

 

7.   Ugalde RA: Intracellular lifestyle of Brucella spp. common genes with other animal pathogens, plant pathogens, and endosymbionts.
Microbes Infect 1999, 1:1211-1219.

    Return to citation in text: [1]

 

8.   Pizarro-Cerda J, Meresse S, Parton RG, van der Goot G, Sola-Landa A, Lopez-Goni I, Moreno E, Grovel JP: Brucella abortus transits through the autophagic pathway and replicates in the endoplasmic reticulum of nonprofessional phagocytes.
Infect Immun 1998, 66:5711-5724. [PubMed Central Full Text]

    Return to citation in text: [1]

 

9.   Comerci DJ, Martinez-Lorenzo MJ, Sieira R, Gorvel JP, Ugalde RA: Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole.
Cell Microbiol 2001, 3:159-168.

    Return to citation in text: [1]

 

10.   Dorn BR, Dunn WA Jr, Progulske-Fox A: Bacterial interactions with the autophagic pathway.
Cell Microbiol 2002, 4:1-10.

    Return to citation in text: [1]

 

11.   Weinberg ED: Pregnancy-associated immune suppression: risks and mechanisms.
Microb Pathog 1987, 3:393-397.

    Return to citation in text: [1]

 

12.   Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon?
Immunol Today 1993, 14:353-356.

    Return to citation in text: [1]

 

13.   Raghupathy R: Th1-type immunity is incompatible with successful pregnancy.
Immunol Today 1997, 18:478-482.

    Return to citation in text: [1] [2] [3] [4]

 

14.   Sano M, Mitsuyama M, Watanabe Y, Nomoto K: Impairment of T cell-mediated immunity to Listeria monocytogenes in pregnant mice.
Microbiol Immunol 1986, 30:165-176.

    Return to citation in text: [1]

 

15.   Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M: Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
J Immunol 1996, 156:644-652.

    Return to citation in text: [1]

 

16.   Zhan Y, Cheers C: Endogenous gamma interferon mediates resistance to Brucella abortus infection.
Infect Immun 1993, 61:4899-4901. [PubMed Central Full Text]

    Return to citation in text: [1] [2]

 

17.   Stevens MG, Pugh GW Jr, Tabatabai LB: Effects of γ-interferon and indomethacin in preventing Brucella abortus infections in mice.
Infect Immun 1992, 60:4407-4409. [PubMed Central Full Text]

    Return to citation in text: [1]

 

18.   O'Callaghan D, Cazevieille C, Allardet-Servent A, Boschiroli ML, Bourg G, Foulongne V, Frutos P, Kulakov Y, Ramuz M: A homologue of the Agrobacterium tumefaciens VirB and Bordetella pertussis Ptl type IV secretion systems is essential for intracellular survival of Brucella suis.
Mol Microbiol 1999, 33:1210-1220.

    Return to citation in text: [1]

 

19.   Sieira R, Comerci DJ, Sanchez DO, Ugalde RA: A homologue of an operon required for DNA transfer in Agrobacterium tumefaciens is required in Brucella abortus for virulence and intracellular multiplication.
J Bacteriol 2000, 182:4849-4855. [PubMed Central Full Text]

    Return to citation in text: [1]

 

20.   Watarai M, Makino S-I, Shirahata T: An essential virulence protein of Brucella abortus, VirB4, requires an intact nucleoside-triphosphate-binding domain.
Microbiology 2002, 184:1439-1446.

    Return to citation in text: [1] [2]

 

21.   Watarai M, Makino S-I, Fujii Y, Okamoto K, Shirahata T: Modulation of Brucella-induced macropinocytosis by lipid rafts mediates intracellular replication.
Cell Microbiol 2002, 4:341-356.

    Return to citation in text: [1] [2] [3]

 

22.   Bosseray N, Plommet M: Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.
Vaccine 1990, 8:462-468.

    Return to citation in text: [1]

 

23.   Jones SM, Winter AJ: Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages.
Infect Immun 1992, 60:3011-3014. [PubMed Central Full Text]

    Return to citation in text: [1]

 

24.   Quinn HE, Ellis JT, Smith NC: Neospora caninum: a cause of immune-mediated failure of pregnancy?
Trend Parasitol 2002, 18:391-394.

    Return to citation in text: [1]

 

25.   Smith H, Williams AE, Pearce JH, Keppie J, Harris-Smith PW, Fitz-George RB, Witt K: Foetal erythritol: a cause of the localization of Brucella abortus Foetal erythritol: in bovine contagious abortion.
Nature 1962, 193:47-49.

    Return to citation in text: [1] [2]

 

26.   Keppie J, Williams AE, Witt K, Smith H: The role of erythritol in tissue localization of the brucellae.
Br J Exp Pathol 1965, 46:104-108.

    Return to citation in text: [1] [2]

 

27.   Payne JM: Changes in the rat placenta and foetus following experimental infection with Brucella abortus.
J Pathol Bacteriol 1957, 73:141-154.

    Return to citation in text: [1]

 

28.   Soares MJ, Chapman BM, Rasmussen CA, Dai G, Kamei T, Orwig KE: Differentiation of trophoblast endocrine cells.
Placenta 1996, 17:277-289.

    Return to citation in text: [1]

 

29.   Cross JC: Genetic insights into trophoblast differentiation and placental morphogenesis.
Semin Cell Dev Biol 2000, 11:105-113.

    Return to citation in text: [1] [2]

 

30.   Ain R, Canham LN, Soares MJ: Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation.
Dev Biol 2003, 260:176-190.

    Return to citation in text: [1] [2] [3]

 

31.   Ashkar AA, Croy BA: Interferon-γ contributes to the normalcy of murine pregnancy.
Biol Reprod 1999, 61:493-502.

    Return to citation in text: [1]

 

32.   Ashkar AA, Di Santo JP, Croy BA: Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.
J Exp Med 2000, 192:259-269.

    Return to citation in text: [1]

 

33.   Ashkar AA, Croy BA: Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy.
Semin Immunol 2001, 13:235-241.

    Return to citation in text: [1]

 

34.   Athanassakis I, Papadimitriou L, Bouris G, Vassiliadis S: Interferon-γ induces differentiation of ectoplacental cone cells to phenotypically distinct trophoblasts.
Dev Comp Immunol 2000, 24:663-672.

    Return to citation in text: [1]

 

35.   Baldwin CL, Winter AJ: Macrophages and Brucella.
Immunol Ser 1994, 60:363-380.

    Return to citation in text: [1]

 

36.   Splitter G, Oliveira S, Carey M, Miller C, Ko J, Covert J: T lymphocyte mediated protection against facultative intracellular bacteria.
Vet Immunol Immunopathol 1996, 54:309-319.

    Return to citation in text: [1]

 

37.   Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-γ.
Annu Rev Immunol 1997, 15:749-795.

    Return to citation in text: [1]

 

38.   Fernandes DM, Benson R, Baldwin CL: Lack of a role for natural killer cells in early control of Brucella abortus.
Infect Immun 1995, 63:4029-4033. [PubMed Central Full Text]

    Return to citation in text: [1]

 

39.   Entrican G: Immune regulation during pregnancy and host-pathogen interactions in infectious abortion.
J Comp Path 2002, 126:79-94.

    Return to citation in text: [1] [2]

 

40.   Medawar PB: Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates.
Symp Soci Exp Biol Med 1953, 7:320-338.

    Return to citation in text: [1]

 

41.   Watarai M, Kim S, Erdenebaatar J, Makino S, Horiuchi M, Shirahata T, Sakaguchi S, Katamine S: Cellular prion protein promotes Brucella infection into macrophages.
J Exp Med 2003, 198:5-17.

    Return to citation in text: [1] [2]

 

42.   Tuo W, O'Rourke KI, Zhuang D, Cheevers WP, Spraker TR, Knowles DP: Pregnancy status and fetal prion genetics determine PrPSc accumulation in placentomes of scrapie-infected sheep.
Proc Natl Acad Sci USA 2002, 99:6310-6315. [PubMed Central Full Text]

    Return to citation in text: [1]

 

43.   Abram M, Schluter D, Vuckovic D, Wraber B, Doric M, Deckert M: Murine model of pregnancy-associated Listeria monocytogenes infection.
FEMS Immunol Med Microbiol 2003, 35:177-182.

    Return to citation in text: [1]

 

  

Return to Last Page



Free Web Sudoku Puzzles.
Solve with your browser.
  6   8 9   5   7
  8   1       4  
          2      
1       4        
9 7           2 3
        7       5
      3          
  2       1   7  
5   4   8 9   1  
What is it?


Add Your Site · Terms Of Service · Privacy Policy


DISCLAIMER
Linkgrinder is a free service that searches the Internet and indexes all files found so that you may search quickly and easily for shared files. These files are created and made available individually by users whose identity we are not aware of and who we have no control over. In essence we function like a search engine tool; these files ARE NOT STORED OR SERVED BY OUR NETWORK. We are not responsible for any materials obtained by using our service. We do not monitor any of the contents of these files. These files may contain viruses, illegal materials, materials inappropriate for minors, offensive files and the like. BY USING OUR SERVICE, YOU ASSUME FULL RESPONSIBILITY FOR DOWNLOADING THESE MATERIALS AND WILL INDEMNIFY US FOR ANY DAMAGES THAT MAY BE INCURRED.

For More Specific Information VIEW OUR TERMS OF SERVICE.

Thank you and Enjoy!